Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Flyer

Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 14
  • Journal CiteScore: 3.77
  • Journal Impact Factor: 4.09
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer

Primary Central Nervous System Lymphoma: A Critical Review of the Role of Surgery for Resection

Google Scholar citation report
Citations : 1140

Archives in Cancer Research received 1140 citations as per Google Scholar report

Flyer image
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • J-Gate
  • Secret Search Engine Labs
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
View More
Share This Page

The effectivity of Artemisia vulgaris extract on Cyclin-D1 and Ki-67 decreased as a supplementation of adenocarcinoma mammae chemotheraphy (study on C3H mice given AC chemotheraphy regimen)

Joint Event on 5th Edition of International Conference on Clinical Oncology and Molecular Diagnostics & 5th World Congress on Medical Imaging & Clinical Research
June 17-18, 2019 Rome, Italy

Aulia Ahimsa Martawiguna, Budijitno S and Handojo D

Diponegoro University, Indonesia

Scientific Tracks Abstracts: Arch Cancer Res

Abstract:

Background: The incidence of breast cancer worldwide is still high. Surgery remains the top choice with other modalities of chemotherapy, radiation and suplementation such as Artemisia vulgaris (AV).v Aim: The study was aimed to demonstrate that administration of AV extract decreased the expression of Cyclin-D1 and the expression of Ki-67 in adenocarcinoma mammae.

Method: This study used "Post test only control group design" on 24 females C3H mice that were randomly selected and divided into four groups: group K (control), P1 (chemotherapy), P2 (extract) and P3 (combination). Adenocarcinoma mammae comes from the inoculation of donor mice. Chemotherapy of Adriamycin 60 mg/m2 and Cyclophosphamide 600 mg/m2 were given in 2 cycles. AV 13 mg (0.2 ml) was given once daily orally. Cyclin- D1expression and Ki-67 expression were evaluated by imunohistochemical staining.

Result: Mean of Cyclin-D1expression and Ki-67 expression were found in groups K, P1, P2, P3 were 35.30+0.72; 20.38+0.67; 33.50+0.71; 17.36+0.66; and 66.44+0.65; 35.40+0.65; 64.12+0.85; 32.32+0.61. The statistical analysis showed that there were significant differences in the expression of Cyclin-D1 between groups of K vs P1, P3 (p=0.001), P1 vs P2 (p=0.001), P1 vs P3 (p=0.045), P2 vs P3 (p=0.001), and in Ki-67 expression between groups of K vs P1, P3 (p=0.001), P1 vs P2 (p=0.001), P1 vs P3 (p=0.041), P2 vs P3 (p=0.001). Correlation analysis between cyclin-D1 expression and Ki-67 expression showed significant correlation (p=0.030 dan r=0.914).

Conclusion: Artemisia vulgaris is potential as supplementation that can improve the effectivity of Adriamycin- Cyclophosphamide chemotherapy in terms of decreased expression of Cyclin-D1 and expression of Ki-67 adenocarcinoma mammae of C3H mice.

Biography :

E-mail:

ahimsamartawiguna@gmail.com

PDF HTML